Skip to content
DraconiticResearch
Search Sources API
203,948 studies31 sourcesUpdated 44 min ago
Peer-reviewedCC BY 4.0Frontiers in Public Health

Cost-effectiveness of an integrated lifestyle intervention for obesity in southern Italy: a model-based simulation of costs, health outcomes and gastrointestinal cancer burden

4 affiliations
  1. 1Scientific Direction, National Institute of Gastroenterology IRCCS “Saverio de Bellis”, Castellana Grotte
  2. 2Unit of Data Science, National Institute of Gastroenterology IRCCS “Saverio de Bellis”, Castellana Grotte
  3. 3Clinical Trial Unit, National Institute of Gastroenterology IRCCS “Saverio de Bellis”, Castellana Grotte
  4. 4Laboratory of Movement and Wellness, National Institute of Gastroenterology IRCCS “Saverio de Bellis”, Castellana Grotte

Abstract

We assessed the cost-effectiveness of a publicly funded lifestyle programme (supervised exercise and nutritional counselling) for adults with obesity (BMI 30.0–34.9 kg/m ² ) in Southern Italy and its projected effect on colorectal and hepatocellular cancer burden. A deterministic cohort state-transition (Markov-type) model with annual cycles simulated 19,000 treatment episodes delivered to 16,736 adults over 20 years, compared with standard of care from societal and payer perspectives. Costs (2024 euros) and QALYs were discounted at 3%. Uncertainty was assessed by one-way and break-even analyses, a 10,000-iteration probabilistic analysis, and an extreme scenario compounding reduced efficacy, higher relapse and a 6% discount rate. The programme yielded 1,354.50 incremental QALYs (0.081 per treated adult) at a net societal cost of €30.06 million: ICER €22,192/QALY societal and €25,987/QALY payer, net monetary benefit €10.58 million at €30,000/QALY. Assuming that sustained weight loss reduced 50% of the excess cancer risk associated with obesity, the model projected a 1.44% relative reduction in incidence (7.2 cases avoided, 95% central range 2.1–16.3, €123,000 in avoided cancer care). The intervention was cost-effective in 67.7% of draws; under the extreme scenario the ICER rose to €183,641/QALY (probability <0.1%). Cost-effectiveness is conditional on sustained adherence and contained relapse rather than inherent.

Related

  1. Effectiveness of a mHealth nutrition and lifestyle intervention (mHENAL) in reducing Cardiovascular Disease Risk in Sri Lankan adults: A Randomized Control Trial
    U. Senarath, P. Katulanda, N. S. Kalupahana +2
    medRxivPreprintPublic domainFull textEpidemiology & public healthmedRxiv
  2. Lifestyle intervention to improve outcomes in dichorionic twin pregnancies: study protocol for a multicentre randomised controlled trial with an integrated pilot study – the LIFETWIN trial
    Katleen Lodewyckx, Yael Winter Shafran, Birgit Coucke +8
    BMJ OpenPeer-reviewedCC BY-NC 4.0Full textObstetrics, gynaecology & paediatricsCrossrefDOAJPMC
  3. Effectiveness of a Sequential Simulation and Online Learning Intervention on Psychiatric Mental Health Nurses’ Motivational Interviewing Knowledge, Confidence, and Skill Performance for Medication Adherence: A Cluster-randomized Controlled Trial
    Wen-Ling Hsieh, I-Hsien Li, Tsui-Mei Hung +2
    Asian Nursing ResearchPeer-reviewedCC BYFull textPhysiologyDOAJ
  4. Investigating the Efficacy of the Proactive Automatised Lifestyle intervention among general hospital patients (ePAL): study protocol of a randomised controlled trial.
    Anne Moehring, Benita Koch, Maike Kuehnel +2
    BMJ openPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMCCrossref
  5. mHealth-based lifestyle intervention for hypertension in community-dwelling adults: a cluster-randomized controlled trial with exploratory multi-omics analyses
    Bin Yu, Haojiang Zuo, Xue Yang +5
    BMC MedicinePeer-reviewedCC BY 4.0General medicineCrossref
BibTeX
@article{polignano2026costeffectiveness,
  title = {{Cost-effectiveness of an integrated lifestyle intervention for obesity in southern Italy: a model-based simulation of costs, health outcomes and gastrointestinal cancer burden}},
  author = {Maurizio Polignano and Davide Guido and Ornella Rotolo and Antonella Bianco and Giuseppe Dalfino and Michelangelo Armenise and Gianluigi Giannelli},
  journal = {Frontiers in Public Health},
  year = {2026},
  month = oct,
  doi = {10.3389/fpubh.2026.1956296},
  url = {https://www.frontiersin.org/articles/10.3389/fpubh.2026.1956296/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Cost-effectiveness of an integrated lifestyle intervention for obesity in southern Italy: a model-based simulation of costs, health outcomes and gastrointestinal cancer burden
AU  - Maurizio Polignano
AU  - Davide Guido
AU  - Ornella Rotolo
AU  - Antonella Bianco
AU  - Giuseppe Dalfino
AU  - Michelangelo Armenise
AU  - Gianluigi Giannelli
PY  - 2026
DA  - 2026/10/29
JO  - Frontiers in Public Health
DO  - 10.3389/fpubh.2026.1956296
UR  - https://www.frontiersin.org/articles/10.3389/fpubh.2026.1956296/full
AB  - We assessed the cost-effectiveness of a publicly funded lifestyle programme (supervised exercise and nutritional counselling) for adults with obesity (BMI 30.0–34.9 kg/m ² ) in Southern Italy and its projected effect on colorectal and hepatocellular cancer burden. A deterministic cohort state-transition (Markov-type) model with annual cycles simulated 19,000 treatment episodes delivered to 16,736 adults over 20 years, compared with standard of care from societal and payer perspectives. Costs (2024 euros) and QALYs were discounted at 3%. Uncertainty was assessed by one-way and break-even analyses, a 10,000-iteration probabilistic analysis, and an extreme scenario compounding reduced efficacy, higher relapse and a 6% discount rate. The programme yielded 1,354.50 incremental QALYs (0.081 per treated adult) at a net societal cost of €30.06 million: ICER €22,192/QALY societal and €25,987/QALY payer, net monetary benefit €10.58 million at €30,000/QALY. Assuming that sustained weight loss reduced 50% of the excess cancer risk associated with obesity, the model projected a 1.44% relative reduction in incidence (7.2 cases avoided, 95% central range 2.1–16.3, €123,000 in avoided cancer care). The intervention was cost-effective in 67.7% of draws; under the extreme scenario the ICER rose to €183,641/QALY (probability <0.1%). Cost-effectiveness is conditional on sustained adherence and contained relapse rather than inherent.
SN  - 2296-2565
ER  -